While both crystallization and data collection can be performed in a highly automated, high-throughput fashion, the numbers of ligands that can be investigated with macromolecular crystallography is strongly limited by manual crystal soaking and mounting. Here we describe a novel generations of pipelines for automated, high-throughput ligand screening with X-ray crystallography. They are based on the combination of the EMBL CrystalDirect technology, enabling completely automated crystal harvesting and cryo-cooling and the MASSIF beamline at ESRF, a fully automated hands-off data collection facility. In addition to automated crystal cryo-cooling and harvesting, the CrystalDirect Technology provides an opportunity to automate soaking experiments through controlled diffusion 1 . This approach supports a gentler delivery (lower osmotic stress) and enables the achievement of higher final ligand concentrations. These new ligand screening pipelines were applied to screen small-molecule libraries targeting proteins of high biomedical relevance leading to the identification and structural characterization of novel ligand protein complexes. These high-throughout, automated, ligand screening pipelines can help streamline the process of structure-based drug design by removing critical bottlenecks and are available to European scientists through the E.C funded H2020 iNEXT project.
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Here we present our research into the structure and dynamics of DNA and DNA-ligand complexes, using a variety of techniques including circular dichroism 1 , X-ray crystallography 2 and ultrafast transient infra-red spectroscopy 3 . By combining these techniques together, we can determine how DNA behaves, and why, under many different conditions and in multiple sample environments. 
